Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by HighteawithIntrepidon Nov 17, 2017 4:44am

182 Views

Post# 26981964

RE:RE:RE:RE:RE:RE:If and when vs when

Pretty simple. PLI is trading at 50% and most of the others
are up, top up the portfolio with an inheritance none of which went into PLI
and we are where we are. The English rules was a positive post by BIO.
I think PL should have stated the SRAM deal was negotiated
in US dollars and the strengthening Canadian dollar has reduced
the amount receivable as of September 30th. I believe
the difference is about 5% less CDN cash receivable. Back to bed.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?